<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02047240</url>
  </required_header>
  <id_info>
    <org_study_id>FILT01</org_study_id>
    <nct_id>NCT02047240</nct_id>
  </id_info>
  <brief_title>Renal Function Determination in Patients With Liver Cirrhosis</brief_title>
  <official_title>Renal Function Determination With Creatinine and Cystatin C Dependent Formulas Compared to Gold Standard DTPA-TC-99 (Diethylene-triamine-pentaacetate- Technetium-99) in Mexican Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We have several ways to appropriately determine renal function in healthy patients and in
      several diseases, in cirrhotic population we dont have a precise tool that has sufficient
      precision that reflects glomerular function, although it has been reported that cystatin C,
      because of its nature could improve diagnostic accuracy to determinate the renal function in
      this population.

      The investigators hypothesize that glomerular filtration obtained from cystatin-C-derived
      formulas are more accurate when compared to creatinine-derived formulas with DTPA-Tc99
      (diethylene-triamine-pentaacetate- technetium-99) as gold standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to determine if the formulas for glomerular filtration are close to
      the estimation of actual renal function in mexican cirrhotic patients of different
      etiologies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of glomerular filtration through several formulas in cirrhotic patients</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of glomerular filtration through several formulas dependent of creatinine and cystatin C and the gold standard</description>
  </primary_outcome>
  <enrollment type="Actual">92</enrollment>
  <condition>Liver Cirrhosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The patients will be selected from the Liver Clinic from the Gastroenterology Department at
        a tertiary care center in Mexico
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver cirrhosis

          -  Stability in creatinine levels in the previous three months (variation &lt;0.3 mg/dL)

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  Hepatocellular carcinoma

          -  Cerebrovascular events

          -  Decompensated heart failure

          -  Drugs that modify serum creatinine levels

          -  Renal replacement therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre, MD MSci</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición &quot;Salvador Zubirán&quot;</name>
      <address>
        <city>Mexico City</city>
        <state>DF</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2014</study_first_submitted>
  <study_first_submitted_qc>January 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2014</study_first_posted>
  <last_update_submitted>June 7, 2016</last_update_submitted>
  <last_update_submitted_qc>June 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>liver cirrhosis</keyword>
  <keyword>glomerular filtration</keyword>
  <keyword>cystatin C</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystatins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

